Teon Therapeutics Competitors and Similar CompaniesClear all

Teon Therapeutics's competitors and similar companies include AstraZeneca, ASLAN Pharmaceuticals, Agenus and BeyondSpring.

	Teon Therapeutics Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.	Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Founding Date	Founding Date 2017	Founding Date 1999	Founding Date N/A	Founding Date 1994	Founding Date 2010
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Redwood City, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations SG HQ Collingwood, AU	Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US	Locations Florham Park, US HQ
Employees	Employees 6	Employees 94,300	Employees 35	Employees 8174% decrease	Employees 4014% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) 96.2 m	Valuation ($) 89.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) $12m (FY, 2023)	Revenue (est.) $114.2m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)	Cost of goods N/A	Cost of goods $1m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $54.2b (FY, 2025)	Gross profit $12m (FY, 2023)	Gross profit $113.2m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income $10.2b (FY, 2025)	Net income ($44.2m) (FY, 2023)	Net income ($3.1m) (FY, 2025)	Net income ($16.7m) (FY, 2024)
Funding
Latest funding round	Latest funding round $ 30m (over 5 years ago)	Latest funding round N/A	Latest funding round $ 23m (almost 10 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 30m	Total funding raised $ 1b	Total funding raised $ 100m	Total funding raised $ 171.1m	Total funding raised $ 36.1m